Oncology pharma stock price

DVAX Dynavax Technologies Corporation. 11.03. +2.80%. Find the latest Curis, Inc. (CRIS) stock quote, history, news and other vital information to help you with your stock trading and investing.

Day's Range 0.0000 - 0.0000. 52 Week Range 0.0000 - 1.0500. Volume 808. Avg. Volume 2,293. Market Cap (intraday) 37. Beta (5Y Monthly) 11.23. PE Ratio (TTM) -- EPS (TTM) …May 8, 2024 · Current Stock Price for Oncology Pharma (ONPH)? A. The stock price for Oncology Pharma ( OTCEM: ONPH) is $ 0.000001 last updated May 8, 2024, 10:33 AM EDT. Q. Aug 19, 2021 · CONTACTS: For additional Information, please contact the Oncology Pharma at: One Sansome Street, Suite 3500 San Francisco, CA 94104 Phone: 415-869-1038 Oncology Pharma (ONPH) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets.Oncology Pharma Inc.: News, information and stories for Oncology Pharma Inc. | OTC Markets: ONPH | OTC MarketsCurrent Stock Price for Oncology Pharma (ONPH)? A. The stock price for Oncology Pharma ( OTCEM: ONPH) is $ 0.000001 last updated May 8, 2024, 10:33 AM EDT. Q.Oncology Pharma (ONPH) Stock Chart & Stock Price History. → AI finds its first serious application (From Wall Street Star) Free ONPH Stock Alerts. $0.06. +0.06 (+11,900.00%) (As of 04/26/2024 08:54 PM ET) Compare. …Feb 28, 2023 · Most Promising Cancer Stocks According to Analysts 11. Bristol-Myers Squibb Company (NYSE:BMY) Number of Hedge Fund Holders: 69. Average Price Target Based on Analyst Ratings: 15.52%

03/23/24-3:30AM EST Benzinga. ONPH: Oncology Pharma - Price and Consensus Chart. Get the latest Price and Consensus Chart for Oncology Pharma from Zacks Investment Research.Find the latest Oncology Pharma Inc. (ONPH) stock quote, history, news and other vital information to help you with your stock trading and investing.0.41%. $91.1B. Astellas Pharma Inc. -1.11%. ¥2.75T. OLMA | Complete Olema Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.See the latest Oncology Pharma Inc stock price (ONPH:PINX), related news, valuation, dividends and more to help you make your investing decisions.The biopharmaceutical company reported ($0.56) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.48) by $0.08. The biopharmaceutical company had revenue of $37.92 million for the quarter, compared to the consensus estimate of $38.73 million.Surface Oncology (SURF) raised $84 million in an IPO on Thursday, April 19th 2018. The company issued 6,000,000 shares at a price of $13.00-$15.00 per share. Goldman Sachs, Cowen and Evercore ISI served as the underwriters for the IPO. This page (NASDAQ:SURF) was last updated on 5/14/2024 by MarketBeat.com Staff.

Oncology Pharma Inc (ONPH) stock is trading at $36.50 as of 1:40 PM on Monday, Jun 21, an increase of $2.82, or 8.37% from the previous closing price of $33.68. The stock has traded between $34.01 and $36.89 so far today. Volume today is low. So far 141,565 shares have traded compared to average volume of 234,886 shares.ONPH - Oncology Pharma Stock Price - Barchart.com. Oncology Pharma Inc (ONPH) Alerts. Watch. Help. Go To: Full Chart. Fundamentals. See More. Market Capitalization, …It’s no secret that investors want to achieve stock market success when they start trading shares — but doing so largely comes down to figuring out the best stocks to invest in and...7 brokers have issued 1 year target prices for Verastem's shares. Their VSTM share price targets range from $17.50 to $36.00. On average, they predict the company's stock price to reach $28.79 in the next year. This suggests a possible upside of 118.7% from the stock's current price.When it comes to purchasing a new vehicle, finding the perfect car that meets all your requirements can be a daunting task. If you have your heart set on a Genesis GV70, you’ll wan...

How old do have to be to work at subway.

Lantern Pharma is leveraging A.I., machine learning & genomics to transform the cost, pace, and timeline of oncology drug discovery and development. See how we are doing it. 01. 02. 03. A Pioneering & World Class Team Dedicated to Creating Novel & Breakthrough Precision Oncology Therapies.Find the latest Oncology Pharma Inc. (ONPH) stock quote, history, news and other vital information to help you with your stock trading and investing.RPHM Price Action: Reneo Pharmaceuticals shares were down 10.8% at $1.61 at the time of writing, according to Benzinga Pro. Image: 385506 from Pixabay. …The three major U.S. stock exchanges are the New York Stock Exchange (NYSE), the NASDAQ and the American Stock Exchange (AMEX). As of 2014, the NYSE is the largest and most prestig...

Market Average Movement. 6.1%. 10% most volatile stocks in US Market. 16.6%. 10% least volatile stocks in US Market. 3.0%. Stable Share Price: ONPH's share price has been volatile over the past 3 months. Volatility Over Time: ONPH's weekly volatility has decreased from 303791% to 186068% over the past year, but is still higher than 75% of US ...Pfizer ( PFE -0.21%) currently markets three blockbuster oncology therapies -- breast cancer drug Ibrance, prostate cancer drug Xtandi, and kidney cancer drug Inlyta. The company also has a dozen ...Stock analysis for Oncology Pharma Inc (SNET:US) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Oct 25, 2023 · Between in or about January and July 2021, Oncology Pharma, Inc. was a thinly traded company that traded on the over-the-counter securities market. In January 2021, Padilla engaged in manipulative trading in ONPH designed, at least in part, to artificially drive up the company’s stock price. 3 Wall Street research analysts have issued 1-year target prices for Ikena Oncology's shares. Their IKNA share price targets range from $8.00 to $11.00. On average, they expect the company's stock price to reach $9.50 in the next twelve months. This suggests a possible upside of 619.7% from the stock's current price.A high-level overview of Oncology Pharma Inc. (ONPH) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Oncology Pharma Inc. analyst ratings, historical stock prices, earnings estimates & actuals. ONPH updated stock price target summary.Real time Oncology Pharma (ONPH) stock price quote, stock graph, news & analysis.For additional Information, please contact the Oncology Pharma at: One Sansome Street, Suite 3500 San Francisco, CA 94104 Phone: 415-869-1038 Fax: 415-946-8801

Shares 1, 40,706,972, Green Equity Designation, No, Week, -5.71. Mkt Cap of share series 2, Green Equity Transition Designation, No, Month, -49.23.

But on today's stock market, Cytokinetics stock tumbled 6.8%, closing at 57.89. Shares have mostly traded below their 50-day moving average since late …24.46. -1.61%. Find the latest Takeda Pharmaceutical Company Limited (TAK) stock quote, history, news and other vital information to help you with your stock trading and investing.Sierra Oncology, Inc. (SRRA.NASDAQ): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Sierra Oncology, Inc. | Nasdaq: SRRA ...Their OLMA share price targets range from $18.00 to $28.00. On average, they predict the company's stock price to reach $21.67 in the next year. This suggests a possible upside of 131.2% from the stock's current price. View analysts price targets for OLMA or view top-rated stocks among Wall Street analysts.A high-level overview of Oncology Pharma Inc. (ONPH) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.View the latest Takeda Pharmaceutical Co. Ltd. ADR (TAK) stock price, news, historical charts, analyst ratings and financial information from WSJ.Find the latest Oncology Pharma Inc. (ONPH) stock quote, history, news and other vital information to help you with your stock trading and investing.Current Stock Price for Oncology Pharma (ONPH)? A. The stock price for Oncology Pharma ( OTCEM: ONPH) is $ 0.000001 last updated May 8, 2024, 10:33 AM EDT. Q.Research Alphamab Oncology's (SEHK:9966) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more. ... Alphamab Oncology and CSPC Pharmaceutical Group Co., Ltd. Announce Approval of IND Application for Pivotal Clinical Study of HER2 Bispecific Antibody KN026 …

King soopers positions.

Red seal pouches.

Track Oncology Pharma Inc (ONPH) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors ... ONPH Oncology Pharma Inc. 1,439. $0.00. $0.00 (0.00%) Today. Watchers: 1,439: 52-Wk Low: $0.00: 52-Wk High: …Understanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price...Oncology Pharma Stock (ONPH) Price Forecast for 2024. Our forecast for ONPH stock price in 2024 now indicates an average price target of $ 1.5481 with a high forecast of $ 2.70 and a low forecast of $ 0.3962. The average prediction reflects an increase of +154810534.33% from the last recorded price of $ 0.000001. Month.Historical Prices. Splits. ONPH Stock Split History. Power to Investors. Subscription Support: 1-347-509-6837. A high-level overview of Oncology Pharma Inc. (ONPH) …Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins an...Lantern Pharma is leveraging A.I., machine learning & genomics to transform the cost, pace, and timeline of oncology drug discovery and development. See how we are doing it. 01. 02. 03. A Pioneering & World Class Team Dedicated to Creating Novel & Breakthrough Precision Oncology Therapies.Oncology Pharma (ONPH) Stock Chart & Stock Price History. → AI finds its first serious application (From Wall Street Star) Free ONPH Stock Alerts. $0.06. +0.06 (+11,900.00%) (As of 04/26/2024 08:54 PM ET) Compare. Stock Analysis Chart Headlines Short Interest.A high-level overview of Oncology Pharma Inc. (ONPH) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Find the latest Oncology Pharma Inc. (ONPH) stock quote, history, news and other vital information to help you with your stock trading and investing.Oncology Pharma (CE) (ONPH) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more. ….

Stock analysis for Oncology Pharma Inc (ONPH:OTC US) including stock price, stock chart, company news, key statistics, fundamentals and company profile.A high-level overview of Oncology Pharma Inc. (ONPH) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.KPRX Kiora Pharmaceuticals, Inc. 0.4862. -0.16%. Find the latest Vincerx Pharma, Inc. (VINC) stock quote, history, news and other vital information to help you with your stock trading and investing.Track Oncology Pharma Inc (ONPH) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsFor additional Information, please contact the Oncology Pharma at: One Sansome Street, Suite 3500 San Francisco, CA 94104 Phone: 415-869-1038 Fax: 415-946-8801Like Pfizer Inc. (NYSE:PFE), Merck & Co., Inc. (NYSE:MRK), and Johnson & Johnson (NYSE:JNJ), Amgen Inc. (NASDAQ:AMGN) is one of the best cancer stocks to buy. ClearBridge Large Cap Value Strategy ...Get the latest Pyxis Oncology Inc (PYXS) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. CRNXCrinetics Pharmaceuticals, Inc. 48.00. -2.87%. YMABY-mAbs Therapeutics, Inc. 12.28. -4.58%. Find the latest Kura Oncology, Inc. (KURA) stock quote, history, news and other vital information to ... Pfizer ( PFE -0.21%) currently markets three blockbuster oncology therapies -- breast cancer drug Ibrance, prostate cancer drug Xtandi, and kidney cancer drug Inlyta. The company also has a dozen ...7 brokers have issued 1 year target prices for Verastem's shares. Their VSTM share price targets range from $17.50 to $36.00. On average, they predict the company's stock price to reach $28.79 in the next year. This suggests a possible upside of 118.7% from the stock's current price. Oncology pharma stock price, [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1]